Adverum Biotechnologies

Company Deals

Eli Lilly to Acquire Adverum Biotechnologies for Up to USD 261.7m for Ixo-vec Access

Fineline Cube Oct 27, 2025

Eli Lilly (NYSE: LLY) announced on October 24, 2025, that it will acquire gene therapy...

Company Deals

Harbour BioMed Boosts Spruce Stake to 3.8%, Advancing SPR202 for Adrenal Disease

Company Drug

Duality’s DB‑1317 ADC Receives IND Approval for ADAM9‑Targeted Solid Tumor Therapy

Company Drug

Biogen’s High‑Dose SPINRAZA Wins EU Approval for 5q SMA After Japan Nod

Company Deals

InventisBio Files for Hong Kong IPO, Betting on Oncology and Metabolic Pipeline